These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24626663)

  • 21. Listeria infections associated with infliximab: case reports.
    Kesteman T; Yombi JC; Gigi J; Durez P
    Clin Rheumatol; 2007 Dec; 26(12):2173-2175. PubMed ID: 17579802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serious liver disease induced by infliximab.
    Tobon GJ; Cañas C; Jaller JJ; Restrepo JC; Anaya JM
    Clin Rheumatol; 2007 Apr; 26(4):578-81. PubMed ID: 16547695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Okada SK; Siegel JN
    JAMA; 2006 Nov; 296(18):2201-2; author reply 2203-4. PubMed ID: 17090760
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumour necrosis factor blockade in rheumatoid arthritis.
    Breedveld FC
    Clin Med (Lond); 2001; 1(2):107-9. PubMed ID: 11333452
    [No Abstract]   [Full Text] [Related]  

  • 25. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
    Gilaberte Y; Coscojuela C; Vázquez C; Roselló R; Vera J
    Br J Dermatol; 2007 Feb; 156(2):368-71. PubMed ID: 17223880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optic neuritis after infliximab therapy.
    Faillace C; de Almeida JR; de Carvalho JF
    Rheumatol Int; 2013 Apr; 33(4):1101-3. PubMed ID: 22198693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis.
    Geraghty EM; Ristow B; Gordon SM; Aronowitz P
    Clin Infect Dis; 2007 May; 44(10):e82-4. PubMed ID: 17443458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice.
    Neven N; Vis M; Voskuyl AE; Wolbink GJ; Nurmohamed MT; Dijkmans BA; Lems WF
    Ann Rheum Dis; 2005 Apr; 64(4):645-6. PubMed ID: 15769924
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How does infliximab work in rheumatoid arthritis?
    Maini RN; Feldmann M
    Arthritis Res; 2002; 4 Suppl 2(Suppl 2):S22-8. PubMed ID: 12110154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and adverse reactions of the TNFalpha inhibitor infliximab in rheumatoid arthritis].
    Imagama T; Taguchi T
    Nihon Rinsho; 2013 Jul; 71(7):1209-13. PubMed ID: 23961668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infliximab: a review of its use in the management of rheumatoid arthritis.
    Markham A; Lamb HM
    Drugs; 2000 Jun; 59(6):1341-59. PubMed ID: 10882166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
    van Rijthoven AW; Bijlsma JW; Canninga-van Dijk M; Derksen RH; van Roon JA
    Rheumatology (Oxford); 2006 Oct; 45(10):1317-9. PubMed ID: 16844698
    [No Abstract]   [Full Text] [Related]  

  • 34. New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients.
    Tanno M; Nakamura I; Kobayashi S; Kurihara K; Ito K
    Clin Rheumatol; 2006 Nov; 25(6):929-33. PubMed ID: 16328088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptococcal meningitis in a patient treated with infliximab.
    Muñoz P; Giannella M; Valerio M; Soria T; Díaz F; Longo JL; Bouza E
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):443-6. PubMed ID: 17240111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.
    Ostör AJ; Chilvers ER; Somerville MF; Lim AY; Lane SE; Crisp AJ; Scott DG
    J Rheumatol; 2006 Mar; 33(3):622-8. PubMed ID: 16511933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [TNF inhibitors for treatment of rheumatoid arthritis].
    Otomo K; Koike T
    Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2405-12. PubMed ID: 19149036
    [No Abstract]   [Full Text] [Related]  

  • 38. Vasculitis, vitiligo, thyroiditis, and altered hormone levels after anti-tumor necrosis factor therapy.
    Lahita RG; Vernace MA
    J Rheumatol; 2011 Mar; 38(3):579-80. PubMed ID: 21362795
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
    Gómez-Reino JJ; Carmona L; Valverde VR; Mola EM; Montero MD;
    Arthritis Rheum; 2003 Aug; 48(8):2122-7. PubMed ID: 12905464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biologicals in treatment of rheumatoid arthritis and other inflammatory arthropathies].
    Sautner J; Leeb BF
    Wien Med Wochenschr; 2003; 153(13-14):304-8. PubMed ID: 12924105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.